Skip to content
NYSE · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · SMALL CAP

Electromed, Inc. ELMD

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$73.8M
▲ 15.3% YoY
$11.3M
▲ 49.9% YoY
$8.4M
▼ 24.4% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 73.8M
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2025 · Revenue 73.8 · Net income 11.3
30M60M
201020132016201920222025
Compound annual growth
+15.4%
+15.6%
+12.4%
+9.5%
+52.8%
+36.8%
+17.7%
+17.1%
+53.4%
+36.9%
+17.0%
+16.6%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +15.6% a year over the five years to FY2025 — but profit grew faster: net income at +36.8%, earnings per share at +36.9%.

The share count fell from 0.01B to 0.01B — the buyback concentrates the same profit into fewer slices.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

15 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 18.8% · Net 15.3%
5%10%15%-5%-10%
201020172025
ROE
FY2025 · ROE 23.3%
10%20%-5%
201020172025
Three returns, three denominators.

Each USD of equity produced 23 cents of profit this year.

Cash & shareholders

USD 3.0M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 8.4
5M10M-1M-2M
201020172025
Net buybacks $M Dividends $M
FY2025 · Dividends · · Net buybacks 3.0
4M8M
202020212022202320242025

USD 3.0M in buybacks — 26% of the year's profit went back to shareholders.

Total assetsUSD 66.3M
EquityUSD 54.0M
CashUSD 20.4M
Current ratio4.69×

Equity funds 81% of total assets.

The 16-year record

16 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
ELMD, 16-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B0.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B0.00.00.00.00.00.00.00.00.00.00.00.0−0.0−0.00.00.0
EBITDA $B0.00.00.00.00.00.00.00.00.00.00.00.0−0.0−0.00.00.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.00.00.0−0.00.00.0
Net income $B0.00.00.00.00.00.00.00.00.00.00.00.0−0.0−0.00.00.0
Free cash flow $B0.00.00.0−0.0−0.00.00.00.00.00.00.00.00.00.0−0.0−0.0
EPS, diluted $1.300.850.580.360.260.270.470.230.210.260.270.13−0.16−0.160.020.13
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend————————————————
ROE %23.317.212.58.86.97.514.98.28.612.314.68.2−9.7−9.21.37.2
Shares out B0.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.01

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 80 reconciliationsAUDITED

Reconciled in 16 of the 16 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: EPS is not tagged before 2010. Three checks were skipped: revenue is not tagged before 2010.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityElectromedical & Electrotherapeutic Apparatus
Listed onNYSE
Incorporated inMinnesota
Fiscal year endsJune 30
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image